FDA Court Loss Shows ‘Disconnect’ Between Old Regulatory Language And Cell Therapy Technology

 
• By Brenda Sandburg
  
Disconnect maze
The gap between old regulatory langage and new technology is problematic for FDA regulation of stem cell treatments • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet